Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PETERSON, Bercedis L")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 35

  • Page / 2
Export

Selection :

  • and

Detecting treatment-by-centre interaction in multi-centre clinical trialsPOTTHOFF, Richard F; PETERSON, Bercedis L; GEORGE, Stephen L et al.Statistics in medicine. 2001, Vol 20, Num 2, pp 193-213, issn 0277-6715Article

No difference in response rate to a mailed survey among prostate cancer survivors using conditional versus unconditional incentivesEVANS, Brian R; PETERSON, Bercedis L; DEMARK-WAHNEFRIED, Wendy et al.Cancer epidemiology, biomarkers & prevention. 2004, Vol 13, Num 2, pp 277-278, issn 1055-9965, 2 p.Article

Clinical research and statistical methods in the urology literatureSCALES, Charles D; NORRIS, Regina D; PETERSON, Bercedis L et al.The Journal of urology. 2005, Vol 174, Num 4, pp 1374-1379, issn 0022-5347, 6 p., 1Article

Home or Nursing Home : Does Place of Residence Affect Longevity in Patients With Alzheimer's Disease? The Experience of CERAD PatientsPETERSON, Bercedis L; FILLENBAUM, Gerda G; PIEPER, Carl F et al.Public health nursing (Boston, Mass.). 2008, Vol 25, Num 5, pp 490-497, issn 0737-1209, 8 p.Article

Rated helpfulness and partner-reported smoking cessation support across the pregnancy-postpartum continuumPOLLAK, Kathryn I; BAUCOM, Donald H; PETERSON, Bercedis L et al.Health psychology (Hillsdale, N.J.). 2006, Vol 25, Num 6, pp 762-770, issn 0278-6133, 9 p.Article

Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia : Justification for risk-adapted therapyBYRD, John C; GRIBBEN, John G; PETERSON, Bercedis L et al.Journal of clinical oncology. 2006, Vol 24, Num 3, pp 437-443, issn 0732-183X, 7 p.Article

Randomized phase 2 study of fludarabine with concurrent versus sequential treatment with rituximab in symptomatic, untreated patients with B-cell chronic lymphocytic leukemia: Results from Cancer and Leukemia Group B 9712 (CALGB 9712)BYRD, John C; PETERSON, Bercedis L; MORRISON, Vicki A et al.Blood. 2003, Vol 101, Num 1, pp 6-14, issn 0006-4971, 9 p.Article

Randomized controlled trial of azacitidine in Patients with the myelodysplastic syndrome: A study of the cancer and leukemia group BSILVERMAN, Lewis R; DEMAKOS, Erin P; ELLERTON, John et al.Journal of clinical oncology. 2002, Vol 20, Num 10, pp 2429-2440, issn 0732-183XArticle

Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trialSWAMY, Geeta K; ROELANDS, Jennifer J; PETERSON, Bercedis L et al.American journal of obstetrics and gynecology. 2009, Vol 201, Num 4, pp 354-356, issn 0002-9378, 3 p.Conference Paper

Phase II trial of sorafenib plus interferon alfa-2b as first-or second-line therapy in patients with metastatic renal cell cancerGOLLOB, Jared A; KIMRYN RATHMELL, W; RICHMOND, Tina M et al.Journal of clinical oncology. 2007, Vol 25, Num 22, pp 3288-3295, issn 0732-183X, 8 p.Article

Analysis of age, estimated creatinine clearance and pretreatment hematologic parameters as predictors of fludarabine toxicity in patients treated for chronic lymphocytic leukemia: a CALGB (9011) coordinated intergroup studyMARTELL, Robert E; PETERSON, Bercedis L; SCHIFFER, Charles A et al.Cancer chemotherapy and pharmacology. 2002, Vol 50, Num 1, pp 37-45, issn 0344-5704, 9 p.Article

Barriers to the participation of African-American patients with Cancer in clinical trials: A pilot studyADVANI, Anjali S; ATKESON, Benjamin; BROWN, Carrie L et al.Cancer. 2003, Vol 97, Num 6, pp 1499-1506, issn 0008-543X, 8 p.Article

Predictors of clinical outcomes in the laparoscopic management of adnexal massesHAVRILESKY, Laura J; PETERSON, Bercedis L; DRYDEN, Damla K et al.Obstetrics and gynecology (New York. 1953). 2003, Vol 102, Num 2, pp 243-251, issn 0029-7844, 9 p.Article

Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trialsKORNBLITH, Alice B; KEMENY, Margaret; PETERSON, Bercedis L et al.Cancer. 2002, Vol 95, Num 5, pp 989-996, issn 0008-543XArticle

Olfactory and Gustatory Sensory Changes to Tobacco Smoke in Pregnant SmokersPLETSCH, Pamela K; POLLAK, Kathryn I; PETERSON, Bercedis L et al.Research in nursing & health. 2008, Vol 31, Num 1, pp 31-41, issn 0160-6891, 11 p.Article

Prospective Trial of Synchronous Bevacizumab, Erlotinib, and Concurrent Chemoradiation in Locally Advanced Head and Neck CancerYOW, David S; KIRKPATRICK, John P; ESCLAMADO, Ramon M et al.Clinical cancer research (Print). 2012, Vol 18, Num 5, pp 1404-1414, issn 1078-0432, 11 p.Article

Safety and Feasibility of Aerobic Training on Cardiopulmonary Function and Quality of Life in Postsurgical Nonsmall Cell Lung Cancer Patients : A Pilot StudyJONES, Lee W; EVES, Neil D; PETERSON, Bercedis L et al.Cancer. 2008, Vol 113, Num 12, pp 3430-3439, issn 0008-543X, 10 p.Article

A critical assessment of the quality of reporting of randomized, controlled trials in the urology literatureSCALES, Charles D; NORRIS, Regina D; KEITZ, Sheri A et al.The Journal of urology. 2007, Vol 177, Num 3, pp 1090-1095, issn 0022-5347, 6 p.Article

Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia : intergroup study cancer and leukemia group B 9011MORRISON, Vicki A; RAI, Kanti R; SCHIFFER, Charles A et al.Journal of clinical oncology. 2001, Vol 19, Num 16, pp 3611-3621, issn 0732-183XArticle

Chemoimmunotherapy With Fludarabine and Rituximab Produces Extended Overall Survival and Progression-Free Survival in Chronic Lymphocytic Leukemia: Long-Term Follow-Up of CALGB Study 9712WOYACH, Jennifer A; RUPPERT, Amy S; HEEREMA, Nyla A et al.Journal of clinical oncology. 2011, Vol 29, Num 10, pp 1349-1355, issn 0732-183X, 7 p.Article

Proactive recruitment of cancer patients' social networks into a smoking cessation trialBASTIAN, Lori A; FISH, Laura J; MCBRIDE, Colleen M et al.Contemporary clinical trials. 2011, Vol 32, Num 4, pp 498-504, issn 1551-7144, 7 p.Article

Further analysis of trials with azacitidine in patients with myelodysplastic syndrome : Studies 8421, 8921, and 9221 by the cancer and leukemia group BSILVERMAN, Lewis R; MCKENZIE, David R; PETERSON, Bercedis L et al.Journal of clinical oncology. 2006, Vol 24, Num 24, pp 3895-3903, issn 0732-183X, 9 p.Article

Prognostic significance of additional cytogenetic abnormalities in newly diagnosed patients with Philadelphia chromosome-positive chronic myelogenous leukemia treated with interferon-α: A cancer and leukemia group B studyFARAG, Sherif S; RUPPERT, Amy S; LARSON, Richard A et al.International journal of oncology. 2004, Vol 25, Num 1, pp 143-151, issn 1019-6439, 9 p.Article

Barriers to clinical trial participation by older women with breast cancerKEMENY, M. Margaret; PETERSON, Bercedis L; KORNBLITH, Alice B et al.Journal of clinical oncology. 2003, Vol 21, Num 12, pp 2268-2275, issn 0732-183X, 8 p.Article

Evaluating the Evidence : Statistical Methods in Randomized Controlled Trials in the Urological LiteratureSCALES, Charles D; NORRIS, Regina D; PREMINGER, Glenn M et al.The Journal of urology. 2008, Vol 180, Num 4, pp 1463-1467, issn 0022-5347, 5 p., 1Article

  • Page / 2